PLEASE NOTE From April 2013 the Greater Manchester Neurosciences Medicines Subgroup has ceased to function, these recommendations have now been superseded by those provided by NHS England see NHS England Specialised Services Commissioning for further information.
By working in partnership across Networks and organisations the aim of the joint subgroups are to develop robust guidance for adoption across the Greater Manchester health economy for the specific disease areas covered by the network.